Insider Trading History of Clemens Peter J Iv

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Clemens Peter J Iv since 2013. The trader's CIK number is 1199421. At the time of the last reporting, Clemens Peter J Iv was the Chief Financial Officer of Enzo Biochem Inc. (stock ticker symbol ENZ). Also see all insider trading activities at Enzo Biochem Inc.

Note that in the past CLEMENS PETER J IV also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Surgical Care Affiliates, Inc. (SCAI) by Clemens Peter J Iv

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 SCAI 0 $0 21,951 $767,726 21,951 $265,607
2013 SCAI 20,000 $480,000 0 $0 0 $0

Yearly summary of insider trading at Enzo Biochem Inc (ENZ) by Clemens Peter J Iv

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ENZ 10,000 $22,060 0 $0 0 $0


Insider trading activities at 2 companies by Clemens Peter J Iv:

1. Surgical Care Affiliates, Inc. (SCAI)

2. Enzo Biochem Inc (ENZ)

Table 1. Insider trading of Surgical Care Affiliates, Inc. (SCAI) by Clemens Peter J Iv

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-03-10 SCAI Sale 18,980 34.98 663,920
2015-03-11 SCAI Option Ex 2,971 12.10 35,949
2015-03-10 SCAI Option Ex 18,980 12.10 229,658
2015-03-11 SCAI Sale 2,971 34.94 103,806
2013-11-04 SCAI Buy 20,000 24.00 480,000

Table 2. Insider trading of Enzo Biochem Inc (ENZ) by Clemens Peter J Iv

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-02-18 ENZ Buy 4,000 2.20 8,800
2020-02-14 ENZ Buy 6,000 2.21 13,260

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clemens Peter J Iv (Chief Financial Officer of Enzo Biochem Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.